Am also wondering whether the “benchmark” cases had a two weeks lead in to screen out ones that heal with standard of care. I haven’t confirm but guessing not?
I’m which case it may be that this standard of care group would do better than the placebo group in the trial, since the trial screens early responders... especially given the number of patients who have been screened but not gone onto the trial...
Just a thought (unsubstantiated).
- Forums
- ASX - By Stock
- DLM
- run coming?
run coming?, page-55
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online